MEA Pingueculum Drugs Market - Industry Trends and Forecast to 2029

MEA Pingueculum Drugs Market - Industry Trends and Forecast to 2029

The Middle East and Africa pingueculum drugs market is projected to register a substantial CAGR of 4.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

Middle East and Africa Pingueculum Drugs Market, By Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops, and Others), Formulation Type (Eye Drops, Eye Ointments, and Others), Mode of Purchase (Prescription, Over the Counter), Drug Type (Branded, Generics), Population Type (Geriatric, Adults), End User (Hospitals, Speciality Clinics, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, and Rest of the Middle East and Africa) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the global pingueculum drugs market are:
 Rise in the prevalence of pingueculum disease around the globe
 Rise in the UV exposure to the individuals due to ozone defect casing pingueculum more frequently
Market Players

Some of the major players operating in the Middle East and Africa pingueculum drugs market are:
• Abbvie Inc.
• Alcon Inc.
• Bausch & Lomb Incorporated
• Bayer AG
• Johnson & Johnson Consumer Inc.
• Novartis AG
• OASIS Medical, Inc.
• Santen Pharmaceutical Co.
• Laboratoires Théa
• Zydus Group